Skip to main content
. 2023 Aug 31;13(9):1272. doi: 10.3390/brainsci13091272

Figure 4.

Figure 4

Cd68 immunoreactivity levels (expressed as % over the contralateral non-lesioned side) in the substantia nigra of 6-OHDA-lesioned mice treated with VCE-003.2 (at an oral dose of 20 mg/kg), L-DOPA/benserazide (at an i.p. dose of 2 mg/kg) or vehicle (sesame oil or 0.9% saline, respectively), and the corresponding controls. Data corresponded to 24 h after the last dose of VCE-003.2 (2 weeks of daily treatment) or L-DOPA (1 week of daily treatment). Values are mean ± SD and were analyzed by one-way ANOVA followed by the Tukey test.